We provided an overview of the role of CNR1 gene in EDs and obesity, in order to further stimulate the challenging idea that the modulation of CNR1 gene transcriptional regulation might represent a promising approach to prevent or to treat these pathologies, in addition to existing pharmacological interventions on CB1R [103]. This evidence concerns the gene CNR1 and obesity disorder.